Pharmacotherapy for Comorbid Alcohol and Drug Use Disorders
The summary for the Pharmacotherapy for Comorbid Alcohol and Drug Use Disorders grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pharmacotherapy for Comorbid Alcohol and Drug Use Disorders: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA) are seeking research grant applications on pharmacological treatment for patients with alcohol use disorder (AUD) and a comorbid substance use disorder (SUD). Substance use disorder may include the abuse/dependence of heroin, prescription narcotics, cocaine, methamphetamine and other stimulants, hallucinogens, sedative hypnotics, marijuana, and other substances of abuse. Alcoholic abuse/dependent patients may have a co-occurring nicotine dependence, but must also meet the criteria for other types of SUD. Research on the specific treatment needs of this population is in early stages, and thus well-designed studies are needed. In particular, it is important to understand how the effects of treating one disorder affects the outcome for the other disorder. The intervention strategy to treat one or both comorbid conditions might depend on the type of comorbidity as well as the subtype of comorbid AUD/SUD patient. In addition, applications can include the utilization of human laboratory paradigms to screen potential medications for subsequent phase 2 and 3 trials as well as to determine the actions of the medications for the treatment of comorbid AUD and SUD. All applications submitted in response to this program announcement should be conducted in humans. In addition, all applicants are encouraged to evaluate the interactions among alcohol, the abused substance and the medication under investigation.
| Federal Grant Title: | Pharmacotherapy for Comorbid Alcohol and Drug Use Disorders |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Education Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PA-04-067 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.27393.279 |
| CFDA Descriptions: | Alcohol Research Programs 93.279 Drug Abuse Research Programs |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
| Posted Date: | Mar 02, 2004 |
| Creation Date: | Mar 02, 2004 |
| Archive Date: | Mar 01, 2007 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster